Subscribe to RSS
DOI: 10.1055/s-0040-1719184
Perinatal Outcomes of Subjects Enrolled in a Multicenter Trial with a Waiver of Antenatal Consent
Funding All phases of this study were supported by the National Institutes of Health and Child Development (1R01HD088646-01A1). The funding source did not have any involvement in the study design, data collection, or data analysis.

Abstract
Objective This study aimed to determine whether outcomes differed between infants enrolled in the PREMOD2 trial and those otherwise eligible but not enrolled, and whether the use of waiver effected these differences.
Study Design The multicenter PREMOD2 (PREmature infants receiving Milking Or Delayed cord clamping) trial was approved for waiver of antenatal consent by six of the nine sites institutional review boards, while three sites exclusively used antenatal consent. Every randomized subject delivered at a site with a waiver of consent was approached for postnatal consent to allow for data collection. Four of those six sites IRBs required the study team to attempt antenatal consent when possible. Three sites exclusively used antenatal consent.
Results Enrolled subjects had higher Apgar scores, less use of positive pressure ventilation, a lower rate of bronchopulmonary dysplasia, and a less frequent occurrence of the combined outcome of severe intraventricular hemorrhage or death. A significantly greater number of infants were enrolled at sites with an option of waiver of consent (66 vs. 26%, risk ratio = 2.54, p < 0.001). At sites with an option of either approaching families before delivery or after delivery with a waiver of antenatal consent, those approached prior to delivery refused consent 40% (range 15–74% across six sites) of the time.
Conclusion PREMOD2 trial demonstrated analytical validity limitations because of the variable mix of antenatal consent and waiver of consent. A waiver of antenatal consent for minimal risk interventional trials conducted during the intrapartum period will be more successful in enrolling a representative sample of low and high-risk infants if investigators are able to enroll all eligible subjects.
Clinical Trial Registration ClinicalTrials.gov identifier: NCT03019367.
Key Points
-
Waiver of consent is when informed consent cannot be obtained prior to delivery.
-
Cord milking is a procedure in which blood is pushed (stripped) two to four times towards the newborn.
-
Delayed clamping means the umbilical cord is not clamped immediately after birth.
Authors' Contributions
A.C.K. conceptualized and designed the study, drafted the initial manuscript, designed the data collection instruments, coordinated and supervised data collection, and approved the final manuscript as submitted. J.E., J.K., E.D., G.M.S., M.V., F.V., W.C., T.Y., and S.B. performed the initial analyses, and coordinated and supervised data collection, reviewed and revised the manuscript, and approved the final manuscript as submitted. K.A., P.A., W.R., and J.M.S. collected the data, performed the initial analyses, reviewed and revised the manuscript, and approved the final manuscript as submitted. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Publication History
Received: 15 September 2020
Accepted: 06 October 2020
Article published online:
03 November 2020
© 2020. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA